The Botulism Treatment market is fundamentally driven by public health necessities and stringent regulatory requirements for handling neurotoxin exposure. With the market expected to grow steadily at a CAGR of 6.50% to reach USD 1.79 billion by 2032, the focus remains firmly on timely diag